Darzalex Faspro Dosage

Generic name: daratumumab and hyaluronidase
Drug class: CD38 monoclonal antibodies

Medically reviewed by  A Ras MD.

Recommended Adult Dosing

Dosage forms:  INJ: 120 mg/2000 units per mL

Multiple myeloma, newly diagnosed

[autologous HSCT ineligible, combo w/ bortezomib, melphalan, and prednisone]
Dose: 1800 mg/30,000 units SC qwk x6 doses, then starting wk 7, give 1800 mg/30,000 units SC q3wk x16 doses, then starting wk 55, give 1800 mg/30,000 units SC q4wk until dz progression; Info: give HSV prophylaxis during tx and x3mo after D/C
[autologous HSCT ineligible, combo w/ lenalidomide and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x8 doses, then starting wk 25, give 1800 mg/30,000 units q4wk until dz progression; Info: give HSV prophylaxis during tx and x3mo after D/C
[autologous HSCT eligible, combo w/ bortezomib, thalidomide, and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x4 doses for total 16wk induction tx, then starting wk 1 after autologous HSCT, give 1800 mg/30,000 units q2wk x4 doses as consolidation tx; Info: give HSV prophylaxis during tx and x3mo after D/C

Multiple myeloma, relapsed or refractory

[combo w/ bortezomib and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x9 doses, then starting wk 10, give 1800 mg/30,000 units SC q3wk x5 doses, then starting wk 25, give 1800 mg/30,000 units SC q4wk until dz progression; Info: give HSV prophylaxis during tx and x3mo after D/C
[combo w/ carfilzomib and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x8 doses, then starting wk 25, give 1800 mg/30,000 units q4wk until dz progression; Info: give HSV prophylaxis during tx and x3mo after D/C
[combo w/ lenalidomide and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x8 doses, then starting wk 25, give 1800 mg/30,000 units q4wk until dz progression; Info: give HSV prophylaxis during tx and x3mo after D/C
[combo w/ pomalidomide and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x8 doses, then starting wk 25, give 1800 mg/30,000 units q4wk until dz progression; Info: for pts refractory to lenalidomide and a proteasome inhibitor; give HSV prophylaxis during tx and x3mo after D/C
[monotherapy]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x8 doses, then starting wk 25, give 1800 mg/30,000 units SC q4wk until dz progression; Info: for pts refractory to at least 3 lines of tx, incl. proteasome inhibitors and immunomodulatory agents; give HSV prophylaxis during tx and x3mo after D/C

Light chain amyloidosis, newly diagnosed

[combo w/ bortezomib, cyclophosphamide, and dexamethasone]
Dose: 1800 mg/30,000 units SC qwk x8 doses, then starting wk 9, give 1800 mg/30,000 units SC q2wk x8 doses, then starting wk 25, give 1800 mg/30,000 units q4wk until dz progression; Max: 2y; Info: give HSV prophylaxis during tx and x3mo after D/C

Renal dosing

CrCl >15: no adjustment; CrCl <15: not defined
HD/PD: not defined

Hepatic dosing

bilirubin 1-1.5x ULN: no adjustment; bilirubin >1.5x ULN: not defined

 

 

SRC: NLM .